Original Article
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 7, 2011; 17(9): 1126-1134
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1126
CT diagnosis of recurrence after pancreatic cancer: Is there a pattern?
Tobias Heye, Nicola Zausig, Miriam Klauss, Reinhard Singer, Jens Werner, Götz Martin Richter, Hans-Ulrich Kauczor, Lars Grenacher
Tobias Heye, Nicola Zausig, Miriam Klauss, Hans-Ulrich Kauczor, Lars Grenacher, Department of Diagnostic and Interventional Radiology, University Hospital, Heidelberg 69120, Germany
Reinhard Singer, Jens Werner, Department of Surgery, University Hospital, Heidelberg 69120, Germany
Götz Martin Richter, Department of Diagnostic and Interventional Radiology, Katharinen Hospital, Stuttgart 70174, Germany
Author contributions: Heye T, Zausig N and Klauss M performed the research; Singer R, Werner J and Richter GM designed the study; Heye T, Zausig N and Singer R collected the data; Kauczor HU, Grenacher L and Heye T analyzed the data; all authors contributed to data interpretation; the paper was mainly written by Heye T and Zausig N with partial but substantial contribution by all other authors; the final version was approved by all authors.
Correspondence to: Tobias Heye, MD, Department of Diagnostic and Interventional Radiology, University Hospital, INF 110, Heidelberg 69120, Germany. tobias.heye@med.uni-heidelberg.de
Telephone: +49-6221-5639391 Fax: +49-6221-565730
Received: September 1, 2010
Revised: December 14, 2010
Accepted: December 21, 2010
Published online: March 7, 2011
Abstract

AIM: To investigate predilection sites of recurrence of pancreatic cancer by computed tomography (CT) in follow-up after surgery.

METHODS: Seventy seven patients with recurrence after pancreatic cancer surgery were retrospectively identified. The operative technique, R-status, T-stage and development of tumor markers were evaluated. Two radiologists analyzed CT scans with consensus readings. Location of local recurrence, lymph node recurrence and organ metastases were noted. Surgery and progression of findings on follow-up CT were considered as reference standard.

RESULTS: The mean follow-up interval was 3.9 ± 1.8 mo, with a mean relapse-free interval of 12.9 ± 10.4 mo. The predominant site of recurrence was local (65%), followed by lymph node (17%), liver metastasis (11%) and peritoneal carcinosis (7%). Local recurrence emerged at the superior mesenteric artery (n = 28), the hepatic artery (n = 8), in an area defined by the surrounding vessels: celiac trunk, portal vein, inferior vena cava (n = 22), and in a space limited by the mesenteric artery, portal vein and inferior vena cava (n = 17). Lymph node recurrence occurred in the mesenteric root and left lateral to the aorta. Recurrence was confirmed by surgery (n = 22) and follow-up CT (n = 55). Tumor markers [carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA)] increased in accordance with signs of recurrence in most cases (86% CA19-9; 79.2% CEA).

CONCLUSION: Specific changes of local and lymph node recurrence can be found in the course of the cardinal peripancreatic vessels. The superior mesenteric artery is the leading structure for recurrence.

Keywords: Pancreatic cancer; Recurrence; Computed tomography; Follow-up; Tumor marker